Minimal Residual Disease in Acute Lymphoblastic Leukemia

1 Views
administrator
administrator
06/15/23

The panelists, Raoul Tibes, MD, PhD; Stefan Faderl, MD; and Bijal D. Shah, MD, outline methods of measuring minimal residual disease and its role in the management of acute lymphoblastic leukemia.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next